UMIN-CTR Clinical Trial

Recruitment status Suspended
Unique ID issued by UMIN UMIN000034024
Receipt No. R000038789
Official scientific title of the study Transition of patient-perceived leg length discrepancy following total joint arthroplasty
Date of disclosure of the study information 2018/09/04
Last modified on 2018/09/04 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Transition of patient-perceived leg length discrepancy following total joint arthroplasty
Title of the study (Brief title) Transition of patient-perceived leg length discrepancy following total joint arthroplasty
Region
Japan

Condition
Condition Osteoarthritis
Classification by specialty
Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Transition of patient-perceived leg length discrepancy following total joint arthroplasty
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase

Assessment
Primary outcomes patient-perceived leg length discrepancy
Key secondary outcomes WOMAC
10m walking speed
rate of each leg weight

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Maneuver
Interventions/Control_1 total joint arthroplasty
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <
Age-upper limit
95 years-old >=
Gender Male and Female
Key inclusion criteria Osteoarthritis
Total joint arthroplasty
Key exclusion criteria ipsilateral osteoarthritis
Target sample size 100

Research contact person
Name of lead principal investigator Iwakiri Kentaro
Organization Shiraniwa Hospital
Division name Orthopaedics
Address 6-10-1 Shiraniwadai Ikoma-city Nara
TEL 0743-70-0022
Email kenpiecekenpiece@yahoo.co.jp

Public contact
Name of contact person Iwakiri Kentaro
Organization Shiraniwa Hospital
Division name Orthopaedics
Address 6-10-1 Shiraniwadai Ikoma-city Nara
TEL 0743-70-0022
Homepage URL
Email kenpiecekenpiece@yahoo.co.jp

Sponsor
Institute Shiraniwa Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 09 Month 04 Day

Progress
Recruitment status Suspended
Date of protocol fixation
2014 Year 01 Month 01 Day
Anticipated trial start date
2014 Year 06 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 09 Month 04 Day
Last modified on
2018 Year 09 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038789